Global Medical Institute, LLC

Princeton, New Jersey 08540

0 studies enrolling now · 4 studies all time

What they study most

Depressive Disorder, Major, Obsessive-Compulsive Disorder

Studies at this site

• Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03) — Completed
• Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder — Stopped early